EUVIMEDEUVIMED entdecken
Crossref

Molecular Interplay Between Gut Barrier Dysfunction and Microglial Activation in Rheumatoid Arthritis: A Comprehensive Review

Lakshmi Santha Macharla, Dr. Suneetha Yaparthi

International Journal of Drug Delivery Technology · 25.05.2026 · 16 (32s)

DOI: 10.25258/ijddt.16.32s.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.05.2026. Verfasst von Lakshmi Santha Macharla und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disorder traditionally characterized by synovial inflammation and joint destruction. Emerging evidence highlights the importance of the joint–gut–brain axis, a bidirectional network integrating immune, neural, and microbial pathways. Gut dysbiosis contributes to increased intestinal permeability ("leaky gut"), allowing translocation of microbial products such as lipopolysaccharides (LPS) into systemic circulation. This promotes widespread immune activation and elevated pro-inflammatory cytokines, including TNF-α, IL-6, and IL-17. These circulating mediators disrupt the bloodbrain barrier (BBB) and activate microglia, the resident immune cells of the central nervous system, leading to neuroinflammation. Activated microglia further release cytokines and neurotoxic mediators, contributing to central sensitization, fatigue, and cognitive dysfunction observed in RA patients. Additionally, neuroinflammation induces autonomic imbalance, particularly vagal suppression, exacerbating gut barrier dysfunction and perpetuating systemic inflammation. This review summarizes current evidence linking gut dysbiosis, microglial activation, and neuroinflammation in RA pathogenesis and highlights potential therapeutic strategies targeting this integrated axis, including microbiota modulation, cytokine inhibition, and neuroimmune regulation.

Zitieren

APA

Macharla, L. S., & Yaparthi, D. S. (2026). Molecular Interplay Between Gut Barrier Dysfunction and Microglial Activation in Rheumatoid Arthritis: A Comprehensive Review. International Journal of Drug Delivery Technology, 16(32s). https://doi.org/10.25258/ijddt.16.32s.20

Vancouver

Macharla LS, Yaparthi DS. Molecular Interplay Between Gut Barrier Dysfunction and Microglial Activation in Rheumatoid Arthritis: A Comprehensive Review. International Journal of Drug Delivery Technology. 2026;16(32s). doi:10.25258/ijddt.16.32s.20

BibTeX
@article{Macharla2026,
  author = {Macharla, Lakshmi Santha and Yaparthi, Dr. Suneetha},
  title = {Molecular Interplay Between Gut Barrier Dysfunction and Microglial Activation in Rheumatoid Arthritis: A Comprehensive Review},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {32s},
  doi = {10.25258/ijddt.16.32s.20}
}
Kostenlos starten →